Goosehead Insurance (GSHD)
(Delayed Data from NSDQ)
$90.44 USD
+1.97 (2.23%)
Updated Oct 9, 2024 03:54 PM ET
After-Market: $90.37 -0.07 (-0.08%) 7:22 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.44 USD
+1.97 (2.23%)
Updated Oct 9, 2024 03:54 PM ET
After-Market: $90.37 -0.07 (-0.08%) 7:22 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Zacks News
MetLife (MET) Collaborates With Savi to Aid Students With Debts
by Zacks Equity Research
MetLife's (MET) Upwise partners with Savi to help students better understand the loan payment process and loan forgiveness eligibility criteria.
Reasons to Hold American International (AIG) Stock for Now
by Zacks Equity Research
Strong General Insurance business, improving premiums and cost-cutting efforts poise American International (AIG) well for growth.
Aflac (AFL) Adds Beneficiary Services to Product Portfolio
by Zacks Equity Research
Aflac (AFL) takes the help of Iris to integrate the Beneficiary Companion service within its life, absence and disability product offerings to ease survivors in settling final affairs post the death of a loved one.
Here's Why You Should Retain MetLife (MET) in Your Portfolio
by Zacks Equity Research
MetLife's (MET) growing partnerships, strong U.S. and Latin America segments, and cost-cutting efforts are aiding its margins.
Oscar Health, Inc. (OSCR) Stock Jumps 56.3%: Will It Continue to Soar?
by Zacks Equity Research
Oscar Health, Inc. (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Why Investors Should Invest in CNO Financial (CNO) Stock Now
by Zacks Equity Research
Strong direct-to-consumer life sales, improving annuity collected premiums and increased Medicare enrolment poise CNO Financial (CNO) well for growth.
Bears are Losing Control Over Goosehead (GSHD), Here's Why It's a 'Buy' Now
by Zacks Equity Research
Goosehead (GSHD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
MetLife (MET) Forms $4B Agriculture Mortgage Loans in 2022
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, supports agricultural producers by initiating $4 billion of agricultural mortgage loans across 400 notes in 2022.
MetLife (MET) Originates $15.1 billion in Private Placement Debt
by Zacks Equity Research
Issuers turning to private debt will increase private placement assets under MetLife's (MET) asset management arm, boosting management fees.
MetLife's (MET) Asset Management Unit Acquires Raven Capital
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, acquires Raven Capital with $2.1 billion in assets under management, aiming to expand its offerings in private credit.
Zacks.com featured highlights UWM Holdings, Perion Network, Lantheus Holdings and Goosehead Insurance
by Zacks Equity Research
UWM Holdings, Perion Network, Lantheus Holdings and Goosehead Insurance have been highlighted in this Screen of The Week article.
Add These 4 Top-Ranked Liquid Stocks For Healthy Gains
by Vaishali Doshi
Here are four top-ranked liquid stocks, Goosehead Insurance (GSHD), Lantheus Holdings (LNTH), Perion (PERI) and UWM Holdings (UWMC), which investors can add to their portfolio for strong gains.
Can Goosehead (GSHD) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Goosehead (GSHD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
New Strong Buy Stocks for February 28th
by Zacks Equity Research
GIB, GSHD, IPG, FTAI and BABA have been added to the Zacks Rank #1 (Strong Buy) List on February 28, 2023.
Goosehead Insurance (GSHD) Misses Q4 Earnings Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -8.33% and 10.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Goosehead (GSHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EverQuote (EVER) Soars 7.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
EverQuote (EVER) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -3.96% and 10.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 33.33% and 6.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Q2 Earnings Lag Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -5.88% and 4.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead Insurance (GSHD) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Goosehead (GSHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in Goosehead (GSHD) Stock?
by Zacks Equity Research
Investors need to pay close attention to Goosehead (GSHD) stock based on the movements in the options market lately.
Goosehead Insurance (GSHD) Q1 Earnings Beat Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of 300% and 0.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Goosehead (GSHD) Stock Jumps 6.1%: Will It Continue to Soar?
by Zacks Equity Research
Goosehead (GSHD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Goosehead Insurance (GSHD) Lags Q4 Earnings Estimates
by Zacks Equity Research
Goosehead (GSHD) delivered earnings and revenue surprises of -40% and 0.45%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?